Overview

Gender

male

Dr. Broder brings more than 30 years of internal medicine and oncology experience to Intrexon. Most notably, Dr. Broder was Director of the National Cancer Institute (NCI) during the Reagan administration, a position he held for six years.

Before joining Intrexon in 2012, Dr. Broder was the Executive Vice President for Medical Affairs and Chief Medical Officer at Celera Corporation, now a division of Quest Diagnostics, where he helped advance the human genome project. While directing NCI, he oversaw the development of many anti-cancer therapeutic agents, helped launch a number of large-scale clinical trials related to the prevention, diagnosis and treatment of cancer, and launched the highly successful SPORE Program.

Dr. Broder also played a major role in developing the first three FDA-approved AIDS treatments. He has served as a board member and as a consultant for numerous pharmaceutical and biotech companies in the U.S. and abroad. Dr. Broder has authored or co-authored more than 340 scientific publications, holds multiple patents, and was elected to the Institute of Medicine of the National Academy of Sciences in 1993. Dr. Broder earned his M.D. from the University of Michigan Medical School in Ann Arbor in 1970.